Abstract
Mesenchymal stem cells (MSCs) are capable of self-renewing and differentiating into multiple tissues; they are expected to become a source of cells for regenerative therapy. Compared to allogeneic MSCs, autologous MSCs from patients needing cell-based therapy may be an ideal alternative stem cell source. However, characterizations of MSCs from a disease state remains extremely limited. Therefore, we have isolated and characterized MSCs from Parkinson’s disease (PD) patients and compared them with MSCs derived from normal adult bone marrow. Our results show that PD-derived MSCs are similar to normal MSCs in phenotype, morphology, and multidifferentiation capacity. Moreover, PD-derived MSCs are capable of differentiating into neurons in a specific medium with up to 30% having the characteristics of dopamine cells. At last, PD-derived MSCs could inhibit T-lymphocyte proliferation induced by mitogens. These findings indicate that MSCs derived from PD patients’ bone marrow may be a promising cell type for cellular therapy and somatic gene therapy applications.
Similar content being viewed by others
References
Ahlskog J. E. Slowing Parkinson’s disease progression. Neurology 60: 381–389; 2003.
Barberi T.; Klivenyi P.; Calingasan N. Y.; Lee H.; Kawamata H.; Loonam K. et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 21: 1200–1207; 2003.
Bartholomew A.; Sturgeon C.; Siatskas M.; Ferrer K.; McIntosh K.; Patil S. et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30: 42–48; 2002.
Brazelton T. R.; Rossi F. M.; Keshet G. I.; Blau H. M; From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290: 1775–1779; 2000.
Conway K. A.; Harper J. D. Lansbury PTAccelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4: 1318–1320; 1998.
Dauer W.; Przedborski S. Parkinson’s disease: mechanisms and models. Neuron 39: 889–909; 2003.
Deans R. J.; Moseley A. B. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 28: 875–84; 2000.
Dezawa M.; Kanno H.; Hoshino M.; Cho H.; Matsumoto N.; Itokazu Y. et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 113: 1701–1710; 2004.
Di Nicola M.; Carlo-Stella C.; Magni M.; Milanesi M.; Longoni P. D.; Matteucci P. et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838–3843; 2002.
Dunnett S. B.; Bjorklund A; . Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature 399: A32–A39; 1999.
Fang B.; Liao L.; Shi M.; Yang S.; Zhao R. C. Multipotency of Flk1+CD34+progenitors derived from human fetal bone marrow. J. Lab. Clin. Med. 143: 230–240; 2005.
Horwitz E. M.; Prockop D. J.; Fitzpatrick L. A. et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5: 309–313; 1999.
Jankovic J. Levodopa strengths and weaknesses. Neurology 58: S19–S32; 2002.
Jiang Y.; Jahagirdar B. N.; Reinhardt R. L. et al. Pluripotency of mesenchymal stem cell derived from adult marrow. Nature 418: 41–49; 2002.
Kasten P.; Vogel J.; Luginbühl R.; Niemeyer P.; Weiss S.; Schneider S. et al. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs 183: 68–79; 2006.
Kawasaki H.; Mizuseki K.; Nishikawa S.; Kaneko S.; Kuwana Y.; Nakanishi S. et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28: 3140; 2000.
Koc O.; Lazarus H. Mesenchymal stem cells heading to the clinic. Bone Marrow Transplant. 27: 235–239; 2001.
Kopen G. C.; Prockop D. J.; Phinney D. G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA 96: 10711–10716; 1999.
Krampera M.; Glennie S.; Dyson J.; Scott D.; Laylor R.; Simpson E. et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722–3729; 2003.
Le Blanc K.; Rasmusson I.; Sundberg B. et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439–1441; 2004.
Lee S. H.; Lumelsky N.; Studer L.; Auerbach J. M.; McKay R. D. G. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol 18: 675–679; 2000.
Makino S.; Fukuda K.; Miyoshi S. et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103: 697–705; 1999.
Mezey E.; Chandross K. J.; Harta G.; Maki R. A.; Mckercher S. R. Turning blood into brain; cells bearing neuronal antigens generated in vivo from bone marrow. Science 290: 1779–1782; 2000.
Minguell J. J.; Conget P.; Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz. J. Med. Biol. Res. 33: 881–887; 2000.
Park S.; Lee K. S.; Lee Y. J.; Shin H. A.; Cho H. Y.; Wang K. C. et al. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci. Lett. 359: 99–103; 2004.
Perrier A. L.; Tabar V.; Barberi T.; Rubio M. E.; Bruses J.; Topf N. et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 101: 12543–12548; 2004.
Pittenger M. F.; Mackay A. M.; Beck S. C. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147; 1999.
Quinn N. P. Parkinson’s disease: clinical features. Baillieres Clin. Neurol. 6: 1–13; 1997.
Reyes M.; Lund T.; Lenvik T. et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615–2625; 2001.
Sakurada K.; Ohshima-Sakurada M.; Palmer T. D.; Gage F. H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126: 4017–4026; 1999.
Sanchez-Ramos J.; Song S.; Cardozo-Pelaez F.; Hazzi C.; Stedeford T.; Willing A. et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164: 247–256; 2000.
Seta Y.; Toyono T.; Takeda S.; Toyoshima K. Expression of Mash1 in basal cells of rat circumvallate taste buds is dependent upon gustatory innervation. FEBS Lett. 444: 4346; 1999.
Tse W. T.; Pendleton J. D.; Beyer W. M.; Egalka M. C.; Guinan E. C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389–397; 2003.
Woodbury D; Schwarz E. J.; Prockop D. J.; Black I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61: 364–370; 2000.
Zhang H.; Huang Z.; Xu Y.; Zhang S. Differentiation and neurological benefit of the mesenchymal stem cells transplanted into the rat brain following intracerebral hemorrhage. Neurol. Res. 28: 104–112; 2006.
Zhao L. R.; Duan W. M.; Reyes M. et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174: 11–20; 2002.
Zheng J. L.; Shou J.; Guillemot F.; Kageyama R.; Gao W. Q. Hes1 is a negative regulator of inner ear hair cell differentiation. Development 127: 4551–4560; 2000.
Acknowledgment
The authors thank all staff of department of Neurology of Dalian People Hospital for the donation and collection of bone marrow samples.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Zhang, Z., Wang, X. & Wang, S. Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson’s disease. In Vitro Cell.Dev.Biol.-Animal 44, 169–177 (2008). https://doi.org/10.1007/s11626-008-9093-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-008-9093-1